Member Info for Uncanny

At least they are getting professional help with any compound negotiations which oozes relief for me. Let the scientists do the science and let Entralta get the best value for shareholders.

If they get a +$250 mn JV deal then it matters not the cost. No win no fee!

Entralta service areas: 2) advising, negotiating, and shepherding on your behalf the sale, acquisition, merger, enforcement, and licensing of your or a third party’s IP assets ;-)

Agreed, should be 5 times higher at least. My system is to keep buying and swallow up as many shares as possible as we have had nothing but positive news and extremely promising developments, particulalry ground breaking over the last 6 months.

As for not been on the radar, maybe we all should give VAL a helping hand and contact on their behalf?

Oh I see, regarding 201 - maybe?! 101 is very promising and possibly the crown jewel and as you say, some pharmas could wish to finance this from an early stage as it is currently in.

Its a market, lots of buying and no stock and the price rises. Lots of sells and plenty of stock then the price falls to a level where willing buyers come in. Simple as! At the moment buyers are meeting sellers and so we are not going anywhere. News will change that, but we are at the bottom end of the trading range so upwards we should go in time.

Tricky, 201 requiring CT II completion, but 401 is ready now, so I expect news first on 401 with commercial partner.

Your all better off calling them direct and putting them on the spot like I have done before! Emails fall on deaf ears.

Why?

Look through the last RNS’s that say they are in talks. Do you think they are lying publically on a highly regulated platform? If you have no trust in the news diseminated on the LSE then you really should sell.

possibly say anything whilst in commercial talks? They could scupper the whole deal just to appease a handful of nervous PI nellies. If you can’t sleep at night because of worry then sell. Many don’t realiae the red tape and hoops that have to be adhered to before new compounds can be released. It is a slow process fro discovery, global patents CT’s to full commercialisation! VAL are on the brink with 201 and CT update plus a trade sale or JV for 401 being imminent. Patience.

Additionally the small quota raised by the recent funding does bot suggest VAL is a company that needs to raise more money. My guess is they are fully funded with a potential deal.

TBB, good posts. Unlike you I don’t really understand the science except for the potential to counter the biggest twentieth century killer. However I do understand investing and the company is so close to commercialisation. I am hoping for a multibag soon on 201 and 401 positive news, but timing is key although fully invested, all paid for and nothing on margin! The quietness is deafening but I understand they can’t murmor a peep because of the sensitiveneas of potential deals, but surely 201 data and 401 JV tie up must be immiennet. The declaration of patents suggests that that was the final tick box to JV. All IMHO

Has anyone emailed the company to confirm (or not)?

I presume we are looking at mid June if I am not mistaken from the timing of the last RNS. There could be fireworks if 201 and 401 are announced together or in short succession. There could even be an all encompassing JV deal / sale etc for both compounds.

Agree Stach. Might see a march on the SP as we approach June in just over a week.

I agree with JJP, the SP is bang on the200 dma @ 2.625p mid

Could come any day: 1.Management indicated that discussions are UNDERWAY with SEVERAL potential partners for the further development of VAL401.

Didn’t Satu say that VAL were in advanced talks with a 401 JV?